Tilray Brands (TLRY) Restructuring Costs (2018 - 2026)
Tilray Brands (TLRY) posted Restructuring Costs of $621000.0 for Q1 2026, down 35.65% on a QoQ basis from $965000.0 in Q4 2025, and down 89.87% year-over-year from $6.1 million in Q1 2025.
Tilray Brands (TLRY) Restructuring Costs (2018 - 2026) Analysis & Trends
Tilray Brands' Restructuring Costs history runs 9 years deep, the most recent figure standing at $621000.0 for Q1 2026.
- Quarterly Restructuring Costs fell 89.87% year-over-year to $621000.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $19.5 million (up 139.66% YoY) and the FY2025 annual result came in at $34.3 million, up 315.5% from the prior year.
- Restructuring Costs was $621000.0 for Q1 2026 at Tilray Brands, down from $965000.0 in the prior quarter.
- Across five years, Restructuring Costs topped out at $17.0 million in Q2 2025 and bottomed at -$1.5 million in Q2 2023.
- A 5-year average of $3.5 million and a median of $1.6 million in 2024 frame the typical range for Restructuring Costs.
- Annual changes were most pronounced in 2023 — Restructuring Costs tumbled 109.43% — and 2025, when it jumped 3527.36%.
- Tilray Brands' Restructuring Costs stood at $2.8 million in 2022, then rose by 8.06% to $3.0 million in 2023, then sank by 70.38% to $901000.0 in 2024, then increased by 7.1% to $965000.0 in 2025, then tumbled by 35.65% to $621000.0 in 2026.
- Business Quant data shows TLRY's Restructuring Costs at $621000.0 in Q1 2026, $965000.0 in Q4 2025, and $869000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 621,000.00 |
| Nov 30, 2025 | 965,000.00 |
| Aug 31, 2025 | 869,000.00 |
| May 31, 2025 | 17.03 Mn |
| Feb 28, 2025 | 6.13 Mn |
| Nov 30, 2024 | 901,000.00 |
| Aug 31, 2024 | 1.60 Mn |
| May 31, 2024 | -497,000.00 |
| Feb 29, 2024 | 3.36 Mn |
| Nov 30, 2023 | 3.04 Mn |
| Aug 31, 2023 | 915,000.00 |
| May 31, 2023 | -1.48 Mn |
| Feb 28, 2023 | 2.66 Mn |
| Nov 30, 2022 | 2.82 Mn |
| Aug 31, 2022 | 445,000.00 |
| May 31, 2022 | 15.72 Mn |
| Feb 28, 2022 | 4.22 Mn |
| Nov 30, 2021 | 7.04 Mn |
| Aug 31, 2021 | 1.19 Mn |
| May 31, 2020 | -8.82 Mn |